ARTICLE | Company News
Chiome, ADC Therapeutics deal
April 11, 2016 7:00 AM UTC
Chiome granted ADC a right to evaluate LIV-2008b and an option to license exclusive, worldwide rights to develop LIV-2008b as an antibody-drug conjugate (ADC) to treat cancer. Chiome is eligible to r...